WHO Guide for standardisation of economic evaluations of immunization programmes.

作者: Damian G. Walker , Raymond Hutubessy , Philippe Beutels

DOI: 10.1016/J.VACCINE.2009.06.035

关键词: Indirect costsPublic healthEconomic evaluationRisk analysis (engineering)Cost-effectiveness analysisQuality (business)Health careCost–benefit analysisMedicineTransparency (graphic)

摘要: Traditional EPI vaccines are considered to be among the most efficient uses of scarce health care resources. Today, there many under-used and new available. In short- medium-term, these will not cost few cents per dose traditional do, but 'multi-dollar' vaccines. Decision-makers need information, other things, on their relative cost-effectiveness. A number reviews have indicated that is scope for improving transparency, completeness comparability economic evaluations vaccination programmes. Thus, a improve quality Adherence general guidelines would increase quality, interpretability transferability future analyses. However, reason believe might also more specific advice For example, inconsistencies in methods used estimate benefits programmes efficiency can sensitive some controversial aspects guidelines, such as inclusion indirect costs discounting outcomes. This guide has been developed order meet needs decision-makers relevant, reliable consistent information. They aim provide clear concise, practical high guidance those who conduct evaluations.

参考文章(30)
Mark Robson, Jon Kim Andrus, Cristiana M. Toscano, Merle Lewis, Lucia Oliveiria, Alba Maria Ropero, Michael Dávila, John W. Fitzsimmons, A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative. Public Health Reports. ,vol. 122, pp. 811- 816 ,(2007) , 10.1177/003335490712200613
Nancy Thiry, Philippe Beutels, Pierre Van Damme, Eddy Van Doorslaer, Economic evaluations of varicella vaccination programmes: a review of the literature. PharmacoEconomics. ,vol. 21, pp. 13- 38 ,(2003) , 10.2165/00019053-200321010-00002
Tom Jefferson, Vittorio Demicheli, Is vaccination against hepatitis b efficient? A review of world literature Health Economics. ,vol. 3, pp. 25- 37 ,(1994) , 10.1002/HEC.4730030105
Chiun-Fang Chiou, Joel W. Hay, Joel F. Wallace, Bernard S. Bloom, Peter J. Neumann, Sean D. Sullivan, Hsing-Ting Yu, Emmett B. Keeler, James M. Henning, Joshua J. Ofman, Development and validation of a grading system for the quality of cost-effectiveness studies. Medical Care. ,vol. 41, pp. 32- 44 ,(2003) , 10.1097/00005650-200301000-00007
Philippe Beutels, Paul A Scuffham, C Raina MacIntyre, Funding of drugs: do vaccines warrant a different approach? Lancet Infectious Diseases. ,vol. 8, pp. 727- 733 ,(2008) , 10.1016/S1473-3099(08)70258-5